// App-Quantinova.ai

224 : Gastric and gastroesophageal adenocarcinoma survival outcomes relative to completion of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A single-center retrospective analysis.

Researchers

Presenter

  • Michael J Allen

Principal Investigators

  • Osvaldo Espin-Garcia

  • Elan David Panov

  • Lucy Xiaolu Ma

  • Chihiro Suzuki

  • Yvonne Bach

  • Gail Elizabeth Darling

  • Jonathan Yeung

  • Sangeetha Kalimuthu

  • Rebecca Wong

  • Patrick Veit-Haibach

  • Raymond Woo-Jun Jang

  • Elena Elimova

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Joint Division of Medical Imaging (JDMI), University Health Network, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Fluorouracil

  • Adrucil injection

  • Oxaliplatin

  • leucovorin

  • Docetaxel

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved